At a glance
Rates* of reported cases† of acute hepatitis B, by state or jurisdiction — United States, 2021–2022
Source: CDC, National Notifiable Diseases Surveillance System.
* Rates per 100,000 population.
† Reported confirmed cases. For the case definition, see Acute Hepatitis B.
Only states with rates for 2021 and 2022 are shown. State/jurisdiction and year for no reported cases: Connecticut (2022, 2021), Hawaii (2022, 2021), New Mexico (2022).
State or jurisdiction ranked in decreasing order by the 2022 rate, 2021 rate, and then alphabetical order by name.
Summary
During 2022, the rates of reported acute hepatitis B ranged from a high of 3.0 cases per 100,000 population in West Virginia to a low of 0.1 in Missouri, Idaho, North Dakota, Alaska, and Rhode Island (not included in Figure 2.2). The largest absolute decrease in rates during 2021–2022 was observed in Tennessee (decrease of 0.4 cases per 100,000 population), whereas the largest absolute increase was observed in Florida (increase of 0.5 cases per 100,000 population).
With the varying availability of resources to conduct viral hepatitis surveillance and the relatively small number of acute hepatitis B cases reported in certain jurisdictions, wide fluctuations in annual rates might occur.